Terry's Tips Stock Options Trading Blog

December 20, 2022 Moderna (MRNA), the company of COVID vaccine fame, announced this week that a cancer vaccine, in combination with a Merck (MRK) drug, showed positive results in a trial on melanoma patients. The stock jumped 20% on the news but then pulled back amid the overall market swoon. Oddly, the stock received a […]

December 12, 2022 Market Like Mongo Database platform provider MongoDB (MDB) reported earnings after the close on Tuesday that topped estimates on all accounts. Adjusted earnings were up sharply from a year earlier, and easily topped the analyst estimate. Revenue was up nearly 50% from a year ago and beat expectations by nearly 10%. And […]

December 5, 2022 Ulta Beauty (ULTA) reported impressive earnings on Thursday after the bell that beat estimates on all counts. Earnings came in more than a dollar higher than expectations, while revenue beat by more than 4%. Same-store sales came in a whopping 60% above the analyst number. Moreover, ULTA raised full-year guidance for both […]

November 28, 2022 Medical-device maker Medtronic (MDT) reported earnings this week that hardly impressed the Street. Quarterly sales and earnings fell from a year earlier, with revenue falling short of analyst expectations while profits met projections. The company also cut its full-year guidance, citing the usual supply-chain disruptions and a slower recovery in medical procedures […]

November 21, 2022 Down Goes Tyson Tyson Foods (TSN) can’t seem to get out of its own way. The company reported earnings on Nov. 14 that missed estimates on profits but beat on revenue. Higher chicken prices squeezed gross margins, which were cut in half. But TSN has other problems. The week before earnings, the […]

November 14, 2022 Oil and gas producer Diamondback Energy (FANG) – which may have the best ticker symbol in finance – reported earnings on Monday that beat analyst expectations on both the top and bottom lines. Higher oil prices led to huge jumps in net income (+82%) and revenue (28%) compared to a year earlier. […]

October 8, 2022 Pharmaceutical giant AbbVie (ABBV) reported mixed results in its recent earnings report. While earnings beat the consensus estimate, revenue fell short. Notably, the company’s immunology portfolio, which includes popular TV-ad drugs such as Humira, fell short of expectations. ABBV’s CEO cited the usual (and seemingly generic) “economic headwinds” as hurting the company’s […]

October 31, 2022 Go With VLO Oil refiner Valero Energy (VLO) reported earnings this week that either missed or beat both profit and revenue estimates, depending on the source. I won’t quibble with who’s right or wrong. What’s important is that revenue and profits soared above the figures from a year ago. Moreover, VLO’s CEO […]

October 24, 2022 Schwab (SCHW) reported earnings on Monday before the open that set records for both earnings per share and revenue. Both numbers exceeded the consensus analyst estimates. SCHW attributed the great quarter to its “diversified financial model and a significant benefit from higher rates.” Analysts didn’t appear moved by the record numbers, though. […]

October 18, 2022 BlackRock (BLK) is the world’s largest asset manager with more than $10 trillion in assets under management (AUM) heading into 2022. But that has changed dramatically, as evidenced by Thursday’s release of BLK’s latest earnings report that showed AUM tumbling 16% in the third quarter. The Ukraine war, high inflation, rising interest […]